[Development of drug delivery system by utilizing absorption from liver surface and its application].
Because it is difficult to achieve local drug activity following administration by the conventional intravenous and oral routes, I sought to develop a new route of administration utilizing drug absorption from the liver surface in order to target that organ. Although direct application to the liver surface should yield local drug distribution, drug absorption from the liver surface has not been reported in the literature. Therefore, we analyzed, as a model, the efficiency of absorption of several organic anions and dextrans of various molecular weights following application to the rat liver surface in vivo using a cylindrical diffusion cell. Each compound appeared gradually in the plasma, followed by excretion into the bile and/or urine, indicating the possibility of drug absorption from the liver surface. The absorption process from the liver surface may not involve a specific transport system because dose and transport inhibitors had no detectable effect. In addition, molecular weight was found to be a determinant of absorption through the liver surface. The efficiency of targeting desired region in the liver was enhanced considerably by application to the liver surface, compared to intravenous administration. Moreover, I have obtained several promising results from the application of this new drug delivery system to anticancer drugs and gene therapy. On the other hand, I have also clarified the characteristics of drug absorption from the surfaces of the kidney, stomach, cecum and small intestine, and plan to apply the physiological findings to other fields.
Nishida
Koyo
K
Division of Pharmaceutics, Department of Clinical Pharmacy, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 854-8521, Japan. koyo-n@nagasaki-u.ac.jp
D000042:Absorption; D000818:Animals; D000970:Antineoplastic Agents / Q000493:pharmacokinetics; D002627:Chemistry, Physical; D004247:DNA / Q000008:administration & dosage; D004333:Drug Administration Routes; D016503:Drug Delivery Systems; D005472:Fluorouracil / Q000493:pharmacokinetics; D015316:Genetic Therapy; D006801:Humans; D008099:Liver / Q000378:metabolism*; D008970:Molecular Weight; D010599:Pharmacokinetics; D010957:Plasmids / Q000008:administration & dosage; D051381:Rats; D014018:Tissue Distribution
D000970:Antineoplastic Agents; D004247:DNA; D005472:Fluorouracil